Paunikar Sharayu, Chakole Vivek
Anesthesiology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus. 2024 Sep 4;16(9):e68597. doi: 10.7759/cureus.68597. eCollection 2024 Sep.
Sepsis and septic shock are leading causes of mortality in intensive care units, characterized by a dysregulated immune response to infection, leading to severe organ dysfunction. Oxygen therapy is a cornerstone of supportive care in sepsis management, aimed at correcting hypoxemia and improving tissue oxygenation. However, the administration of supplemental oxygen must be carefully managed to avoid hyperoxia, which can lead to oxidative stress and additional tissue damage. This review aims to comprehensively analyze the clinical evidence regarding hyperoxia in the context of sepsis and septic shock, evaluating its potential therapeutic benefits and risks and discussing the implications for clinical practice. A thorough literature review included observational studies, randomized controlled trials (RCTs), meta-analyses, and clinical guidelines. The review focuses on the pathophysiology of sepsis, the mechanisms of hyperoxia-induced injury, and the clinical outcomes associated with different oxygenation strategies. The evidence suggests that while oxygen is crucial in managing sepsis, the risk of hyperoxia-related complications is significant. Hyperoxia has been associated with increased mortality and adverse outcomes in septic patients due to mechanisms such as oxidative stress, impaired microcirculation, and potential worsening of organ dysfunction. RCTs and meta-analyses indicate that conservative oxygen therapy may be beneficial in reducing these risks, though optimal oxygenation targets remain under investigation. This review highlights the importance of careful oxygen management in sepsis and septic shock, emphasizing the need for individualized oxygen therapy to avoid the dangers of hyperoxia. Further research is required to refine oxygenation strategies, establish clear clinical guidelines, and optimize outcomes for sepsis and septic shock patients. Balancing adequate oxygenation with the prevention of hyperoxia-induced injury is crucial in improving the prognosis of these critically ill patients.
脓毒症和脓毒性休克是重症监护病房患者死亡的主要原因,其特征是对感染的免疫反应失调,导致严重的器官功能障碍。氧疗是脓毒症治疗中支持性治疗的基石,旨在纠正低氧血症并改善组织氧合。然而,必须谨慎管理补充氧气的给予,以避免高氧血症,因为高氧血症会导致氧化应激和额外的组织损伤。本综述旨在全面分析脓毒症和脓毒性休克背景下高氧血症的临床证据,评估其潜在的治疗益处和风险,并讨论其对临床实践的影响。全面的文献综述包括观察性研究、随机对照试验(RCT)、荟萃分析和临床指南。该综述聚焦于脓毒症的病理生理学、高氧血症诱导损伤的机制以及与不同氧合策略相关的临床结局。证据表明,虽然氧气在脓毒症治疗中至关重要,但高氧血症相关并发症的风险很大。由于氧化应激、微循环受损以及器官功能障碍可能恶化等机制,高氧血症与脓毒症患者死亡率增加和不良结局相关。随机对照试验和荟萃分析表明,保守氧疗可能有助于降低这些风险,不过最佳氧合目标仍在研究中。本综述强调了在脓毒症和脓毒性休克中谨慎进行氧疗管理的重要性,强调需要个体化氧疗以避免高氧血症的危害。需要进一步研究以完善氧合策略、制定明确的临床指南并优化脓毒症和脓毒性休克患者的治疗结局。在改善这些重症患者的预后方面,平衡充足氧合与预防高氧血症诱导的损伤至关重要。